Copyright Reports & Markets. All rights reserved.

Global Hydrocortisone Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Hydrocortisone Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Cream
      • 1.4.3 Injection
      • 1.4.4 Table
    • 1.5 Market by Application
      • 1.5.1 Global Hydrocortisone Market Share by Application (2014-2025)
      • 1.5.2 Adrenocortical Dysfunction
      • 1.5.3 Adrenergic Syndrome
      • 1.5.4 High Blood Calcium
      • 1.5.5 Thyroiditis
      • 1.5.6 Rheumatoid Arthritis
      • 1.5.7 Dermatitis
      • 1.5.8 Asthma and Chronic Obstructive Pulmonary Disease
      • 1.5.9 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Hydrocortisone Market Size
    • 2.2 Hydrocortisone Growth Trends by Regions
      • 2.2.1 Hydrocortisone Market Size by Regions (2014-2025)
      • 2.2.2 Hydrocortisone Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Hydrocortisone Market Size by by Players
      • 3.1.1 Global Hydrocortisone Revenue by by Players (2014-2019)
      • 3.1.2 Global Hydrocortisone Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Hydrocortisone Market Concentration Ratio (CR5 and HHI)
    • 3.2 Hydrocortisone Key Players Head office and Area Served
    • 3.3 Key Players Hydrocortisone Product/Solution/Service
    • 3.4 Date of Enter into Hydrocortisone Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Hydrocortisone Market Size by Type (2014-2019)
    • 4.2 Global Hydrocortisone Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Hydrocortisone Market Size (2014-2019)
    • 5.2 Hydrocortisone Key Players in United States
    • 5.3 United States Hydrocortisone Market Size by Type
    • 5.4 United States Hydrocortisone Market Size by Application

    6 Europe

    • 6.1 Europe Hydrocortisone Market Size (2014-2019)
    • 6.2 Hydrocortisone Key Players in Europe
    • 6.3 Europe Hydrocortisone Market Size by Type
    • 6.4 Europe Hydrocortisone Market Size by Application

    7 China

    • 7.1 China Hydrocortisone Market Size (2014-2019)
    • 7.2 Hydrocortisone Key Players in China
    • 7.3 China Hydrocortisone Market Size by Type
    • 7.4 China Hydrocortisone Market Size by Application

    8 Japan

    • 8.1 Japan Hydrocortisone Market Size (2014-2019)
    • 8.2 Hydrocortisone Key Players in Japan
    • 8.3 Japan Hydrocortisone Market Size by Type
    • 8.4 Japan Hydrocortisone Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Hydrocortisone Market Size (2014-2019)
    • 9.2 Hydrocortisone Key Players in Southeast Asia
    • 9.3 Southeast Asia Hydrocortisone Market Size by Type
    • 9.4 Southeast Asia Hydrocortisone Market Size by Application

    10 India

    • 10.1 India Hydrocortisone Market Size (2014-2019)
    • 10.2 Hydrocortisone Key Players in India
    • 10.3 India Hydrocortisone Market Size by Type
    • 10.4 India Hydrocortisone Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Hydrocortisone Market Size (2014-2019)
    • 11.2 Hydrocortisone Key Players in Central & South America
    • 11.3 Central & South America Hydrocortisone Market Size by Type
    • 11.4 Central & South America Hydrocortisone Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Hydrocortisone Introduction
      • 12.1.4 Pfizer Revenue in Hydrocortisone Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Sanofi
      • 12.2.1 Sanofi Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Hydrocortisone Introduction
      • 12.2.4 Sanofi Revenue in Hydrocortisone Business (2014-2019)
      • 12.2.5 Sanofi Recent Development
    • 12.3 Teva
      • 12.3.1 Teva Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Hydrocortisone Introduction
      • 12.3.4 Teva Revenue in Hydrocortisone Business (2014-2019)
      • 12.3.5 Teva Recent Development
    • 12.4 Akorn
      • 12.4.1 Akorn Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Hydrocortisone Introduction
      • 12.4.4 Akorn Revenue in Hydrocortisone Business (2014-2019)
      • 12.4.5 Akorn Recent Development
    • 12.5 GSK
      • 12.5.1 GSK Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Hydrocortisone Introduction
      • 12.5.4 GSK Revenue in Hydrocortisone Business (2014-2019)
      • 12.5.5 GSK Recent Development
    • 12.6 Bausch and Lomb
      • 12.6.1 Bausch and Lomb Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Hydrocortisone Introduction
      • 12.6.4 Bausch and Lomb Revenue in Hydrocortisone Business (2014-2019)
      • 12.6.5 Bausch and Lomb Recent Development
    • 12.7 Bayer Pharmas
      • 12.7.1 Bayer Pharmas Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Hydrocortisone Introduction
      • 12.7.4 Bayer Pharmas Revenue in Hydrocortisone Business (2014-2019)
      • 12.7.5 Bayer Pharmas Recent Development
    • 12.8 Macleods Pharmaceuticals
      • 12.8.1 Macleods Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Hydrocortisone Introduction
      • 12.8.4 Macleods Pharmaceuticals Revenue in Hydrocortisone Business (2014-2019)
      • 12.8.5 Macleods Pharmaceuticals Recent Development
    • 12.9 Casper Pharma
      • 12.9.1 Casper Pharma Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Hydrocortisone Introduction
      • 12.9.4 Casper Pharma Revenue in Hydrocortisone Business (2014-2019)
      • 12.9.5 Casper Pharma Recent Development
    • 12.10 Dow Pharma
      • 12.10.1 Dow Pharma Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Hydrocortisone Introduction
      • 12.10.4 Dow Pharma Revenue in Hydrocortisone Business (2014-2019)
      • 12.10.5 Dow Pharma Recent Development
    • 12.11 Fougera Pharms
    • 12.12 Hikma Intl Pharms
    • 12.13 Impax Labs
    • 12.14 Ivax Pharms
    • 12.15 Lannett
    • 12.16 Merck
    • 12.17 Novartis
    • 12.18 Salix Pharms
    • 12.19 Sandoz
    • 12.20 TARO
    • 12.21 Valeant
    • 12.22 Wockhardt
    • 12.23 Farmak JSC
    • 12.24 Solvay Pharma
    • 12.25 Alcon
    • 12.26 Paladin Labs
    • 12.27 Adcock Ingram
    • 12.28 ADARE Pharmaceuticals
    • 12.29 Aspen Holdings
    • 12.30 Astellas Pharma

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Hydrocortisone market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Hydrocortisone status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hydrocortisone development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Sanofi
      Teva
      Akorn
      GSK
      Bausch and Lomb
      Bayer Pharmas
      Macleods Pharmaceuticals
      Casper Pharma
      Dow Pharma
      Fougera Pharms
      Hikma Intl Pharms
      Impax Labs
      Ivax Pharms
      Lannett
      Merck
      Novartis
      Salix Pharms
      Sandoz
      TARO
      Valeant
      Wockhardt
      Farmak JSC
      Solvay Pharma
      Alcon
      Paladin Labs
      Adcock Ingram
      ADARE Pharmaceuticals
      Aspen Holdings
      Astellas Pharma

      Market segment by Type, the product can be split into
      Cream
      Injection
      Table

      Market segment by Application, split into
      Adrenocortical Dysfunction
      Adrenergic Syndrome
      High Blood Calcium
      Thyroiditis
      Rheumatoid Arthritis
      Dermatitis
      Asthma and Chronic Obstructive Pulmonary Disease
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Hydrocortisone status, future forecast, growth opportunity, key market and key players.
      To present the Hydrocortisone development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Hydrocortisone are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now